Clinical Trial Update: Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial [Phase 4]

View source ↗

Summary

Phase 4 pediatric trial assessing adalimumab level-based optimization (PAILOT) for Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Schneider Children's Medical Center, Israel | Conditions: Crohn's Disease | Phase 4 | Status: COMPLETED